Synthetic Mesh in Immediate Breast Reconstruction by Gómez-Modet, Susana & Tejedor, Luis
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Synthetic Mesh in Immediate 
Breast Reconstruction
Susana Gómez-Modet and Luis Tejedor
Abstract
The use of biological matrices in immediate implant-based breast reconstruc-
tion arose with the need to reinforce the lower pole of the breast and to cover the 
implant to reduce the risk of implant exposure. Synthetic mesh appears to be a 
lower cost alternative to biological matrices. This literature review aims to assess the 
usefulness of the use of synthetic meshes in breast reconstruction compared with 
the traditional techniques and whether outcomes and complications of synthetic 
meshes and biological matrices are comparable. The positioning of the implants and 
meshes, either submuscular or subcutaneous, has also been considered.
Keywords: breast cancer, breast reconstruction, synthetic breast meshes,  
biological breast meshes, complications of breast reconstruction
1. Introduction
Breast cancer is a life-changing diagnosis. Presently, breast conserving therapy 
can be performed in 70–80% of all breast cancer patients, but in about 20–30% of 
them mastectomy is indicated as the primary therapeutic management [1–3]. As 
mastectomy can profoundly affect body image and self-esteem, breast reconstruc-
tion should be offered to improve quality of life. Reconstruction may be immediate 
or delayed, performed with implants or autologous tissue. Immediate reconstruc-
tion has several advantages: it provides a psychological benefit, reducing emotional 
stress and helping to preserve a positive body image [4, 5].
Numerous surgical techniques have been developed, including the use of 
autologous tissue flaps or silicone implants with or without prior insertion of a 
tissue expander [1]. Implant-based breast reconstruction (IBBR) accounts for 
approximately 40–60% of all breast reconstructions in Europe and around 75% 
in the United States [6]. The American Society of Plastic Surgeons documented 
a 4% increase in these techniques from 2014 to 2015 and a 35% increase over the 
last 15 years. A similar trend has also been shown in the United Kingdom, where 
the rate of IBBR has doubled over the period 1996–2012 [7]. As the number of 
autologous procedures remains approximately the same, the increased number 
of immediate procedures can be primarily attributed to an increase in implant/
expander reconstructions. This number has substantially increased since skin- and 
nipple-sparing mastectomies (SSM/NSM) have proven to be oncologically safe 
procedures.
In IBBR, complete implant coverage has been the mainstay target of surgeons 
in order to reduce the risk of implant exposure [8]. In the last years, biological 
and synthetic meshes have emerged as a useful adjunct to breast reconstruction, 
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although the decision to add some mesh to an alloplastic reconstruction is contro-
versial. However, there is no high-quality evidence comparing clinical and patient-
reported outcomes with mesh-assisted IBBR and traditional IBBR [9]. Finally, the 
decision for using mesh or not and a particular type of matrix or mesh depends 
predominately on the surgeons’ experience [3, 10].
2. Methods
A literature search has been performed in PubMed, Cochrane, and Embase 
databases using the keywords “Breast” and “Reconstruction” and “Mesh” and 
“Synthetic” which rendered 80, 3, and 107 articles, respectively. No date limits 
were set.
Papers written in English reporting on the complications and/or outcome of 
IBBR in women aged 18 years or over, either with expander or implants, as a single- 
or two-stage procedure, either immediate or delayed, both in submuscular and in 
prepectoral position in which synthetic meshes had been used, were selected for 
inclusion. Authors screened these articles discarding duplicates, those reporting less 
than 10 cases, and those unrelated to the subject, leaving a total of 49 papers. The 
reference list of the retrieved studies was searched manually looking for potentially 
relevant reports.
3. Synthetic meshes
Usually, the term “matrices” are used for biological materials and the term 
“meshes” for synthetic materials. There are numerous studies explaining the pros 
and cons of the matrices, but minimal data are available regarding the synthetic 
meshes.
Biological meshes or matrices are flexible sheets of tissue that have been stripped 
of their antigenic cells through a specialised procedure, resulting in decellularisa-
tion but leaving the extracellular matrix intact. They provide a scaffold of tissue 
that the patient’s own cells can repopulate and revascularise.
The acellular dermal matrix (ADM), introduced in 1994 [11], is a plate of 
dermis produced from cadaveric human (Alloderm, Allured, Allomax, Flex HD, 
Dermacell, Dermamatrix, NeoForm), porcine (Strattice, Permacol, Protexa, 
XenMartix, XCM), or bovine (SurgiMend) dermis. Other biological meshes 
come from bovine pericardium (Veritas, Tutopatch, Periguard, Esaflex), porcine 
peritoneum (Meso Biomatrix), bovine intestine (Surgisis), or fish skin (Kerecis 
Omega 3 Pectus) [3]. Their utility has been demonstrated in various reconstructive 
techniques, particularly in burn, abdominal wall repair, and breast reconstruction 
[11–13].
With the introduction of these meshes, the indications for IBBR became 
extended, since they provided surgeons with alternative means of obtaining suffi-
cient vascularized soft tissue to cover the implant. Breuing first reported the use of 
human acellular dermis in IBBR in 2005 [14]. Increased filling volumes of expand-
ers and improved aesthetic outcomes have been reported since then by several 
authors [4, 15–17]. As new data become available, the use of biological meshes in 
IBBR will evolve in the following years.
Synthetic meshes are flexible sheets made of plastic-like material that may play 
a similar role to biological ones in breast reconstruction, becoming an alternative 
with low cost. The tensile strength of most of these materials is enough to support 
the physiological demand, although an excessive strength increases inflammation 
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and decreases elasticity. The size of their pores directly impacts on the incorpora-
tion of the mesh into the surrounding tissues. Small pores generate a strong inflam-
matory response that can reduce tissue ingrowth; larger pores allow more ingrowth, 
preserving elasticity, but promoting more fibrous tissue. Moreover, the mesh can be 
constructed by knitting or weaving the material. Knitted meshes are generally more 
porous and flexible than woven meshes that, because of the increased fibre density, 
are generally stronger and are a poor skeleton for fibrous ingrowth [18].
Besides that, these meshes may be absorbable or non-absorbable. The former are 
made of polyglycolic acid (Dexon), polyglactin (Vicryl)—both of them are resorbed 
within a few months—a copolymer of glycolide, lactide and trimethylene carbonate 
(TIGR Matrix), silk protein (SERI Surgical Scaffold), or a poly-4-hydroxybutyrate 
polymer (Galatea Scaffold) which is long-term resorbable. Non-absorbable meshes 
are composed of polypropylene (PP), polyester, (Mersilene), or expanded polytet-
rafluoroethylene, though just the first material has been used in breast reconstruc-
tion (TiLOOP Bra, ULTRAPRO, SERAGYN BR).
3.1 Vicryl
Vicryl mesh is comprised of polyglactin 910 and is a cheap, ready-to-use, 
and widely available mesh. It causes minimal inflammatory reaction and is non-
allergenic and resistant to bacteria biofilm formation. However, because of its rapid 
resorption, it does not provide a long-lasting tissue reinforcing advantage.
3.2 TiLOOP
This mesh is made of non-resorbable, titanised, lightweight PP with a mono-
filament structure and was initially invented for hernia repair, showing a good 
biocompatibility. Production involves introducing titanium in gaseous form so 
that it reaches all parts of the mesh, forming covalent bonds with the plastic 
surface. Cellular reactions like proliferation and apoptosis were at the lowest level 
when using this material compared to not titanium-coated mesh (pure PP), pure 
lightweight PP mesh, or PP mesh incorporating resorbable polyglactic acid, thus 
reducing the inflammatory reaction and causing significantly less shrinkage [10]. 
Clinical studies show that 2 1/2 months after their use, the mesh fibres have been 
well embedded in the surrounding tissue.
TiLOOP® Bra is intended for extension of the pectoralis major, in the case of 
subpectoral, implant-based (permanent implant or expander) breast reconstruc-
tion. It covers and fixes the caudal pole of the breast implant (Figure 1). TiLOOP 
Bra Pocket is designed to cover a prepectoral implant, providing tissue supporting 
and preventing displacement.
3.3 SERAGYN BR
The SERAGYN BR mesh is a tightly woven, partially resorbable mesh made 
of polyglycolic acid-caprolactone and PP. The resorbable part is absorbed within 
90–120 days while the non-resorbable part remains in place for additional support. 
Its biocompatibility is similar to that of the TiLOOP Bra, although surgeons have 
reported more difficult intraoperative handling due to its firmer characteristics [10].
3.4 ULTRAPRO mesh
ULTRAPRO is manufactured from approximately equal parts of absorbable 
poliglecaprone-25 monofilament fibre and non-absorbable PP monofilament fibre. 
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The absorbable poliglecaprone part of the mesh helps keep the PP structure rigid, 
thus making intraoperative manipulation and positioning of the mesh easier. The 
poliglecaprone-25 copolymer is essentially absorbed at 84 days after implantation, 
remaining only the PP component. Due to the wide pore construction of the mesh, 
a strong, three-dimensional collagen fibre network is formed [19].
3.5 SERI surgical scaffold
This bioengineered mesh is derived from silk purified to result in ultrapure 
fibroin (one of the two proteins of the silk). It is a knitted, multifilament, macropo-
rous, and long-term bioresorbable mesh (more than 24 months) intended to resorb 
slowly, while neovascularization and tissue ingrowth occur. Accordingly, it behaves 
more like an ADM mesh since it is not just absorbed but accompanied by new tissue 
generation so that its strength is transferred to the newly ingrown tissue [20].
3.6 TIGR matrix
TIGR Matrix is a long-term resorbable synthetic mesh. The fast-resorbing fibre 
is a copolymer of lactide, glycolide, and trimethylene carbonate, while the slow-
resorbing part is a copolymer of lactide and trimethylene carbonate, completely 
absorbed after 3 years. Despite its description “matrix” (a term generally used to 
refer to biological products), the mesh is manufactured synthetically. After implan-
tation, the synthetic fibres degrade at different rates by bulk hydrolysis. It provides 
additional support in the first 6 months, and complete resorption is achieved after 
3 years. In vivo investigations revealed good biocompatibility with the formation 
of blood vessels and well-structured collagen fibres. The largest series using these 
meshes is reported by Becker and Lind [21].
3.7 Galatea scaffold
This mesh is made of a poly-4-hydroxybutyrate (P4HB) polymer, which 
degrades primarily by bulk hydrolysis into a natural metabolite (4HP) that is rapidly 
metabolised via the Krebs cycle and eliminated as carbon dioxide and water. The 
mesh is a knitted macroporous scaffold intended to elevate, reinforce, and repair 
soft tissue. It acts as a lattice for new tissue growth, which is rapidly vascularised 
and becomes fully integrated with adjacent tissue as the fibres resorb. It retains 50% 
Figure 1. 
Tiloop bra.
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of its strength at 16 weeks in vivo and provides a gradual transfer of strength to host 
tissue over the course of 52 weeks. It is essentially fully resorbed by 18–24 months, 
allowing the formation of mature strong healthy collagen to support the repair. Its 
use in breast surgery has recently been described [22].
4. Surgical technique
Primary candidates for mesh reconstruction are patients suited for heterolo-
gous breast reconstruction with a small, mid-sized breast and moderate ptosis. 
Preoperative planning is necessary. Markings must be performed on the day with 
the patients in an upright position and including the middle and parasternal lines, 
inframammary folds, and the incision site [23]. There are some possibilities con-
cerning the type of incision technique; in most of the cases, surgeons chose infra-
mammary fold, inverted T, or periareolar.
Prosthetic submuscular IBBR is the most frequent type of reconstruction 
technique performed nowadays. Placing the implant under the muscular plane 
traditionally had less major complications than the subcutaneous technique, not-
withstanding its burden of pain, limited expansion, implant dislocation, and breast 
animation. However, adding a mesh to the prepectoral prosthesis allows a complete 
implant envelope, confers an extra cover, acts as an internal “bra” to relieve pres-
sure on the skin, and defines the implant pocket, preventing lateral displacement. 
The acceptable complication rate reported in the published studies using this 
procedure, although with short-term follow-up, has revived this technique [7] 
(Figure 2).
In the submuscular IBBR, after completion of the mastectomy flaps, the 
inferomedial pectoralis major muscle is elevated for implant placement, serving as 
a cover towards the maximal thinned out mastectomy flap. Usually, this coverage 
can often be achieved only for the upper and lower medial quadrant, which can 
lead to increased implant palpability, with a lack of support and subsequent skin 
erosion. Although additional coverage can be obtained by mobilising the serratus or 
the anterior layer of the rectus muscle, this approach involves even more trauma to 
native tissue and may not be technically possible, particularly in thin patients.
The mesh is fixed to the inferior border of the released pectoral major muscle 
using running or interrupted resorbable sutures. After placing the implant under 
the muscle, the mesh is spread over the implant and fixed to the inframammary 
fold either by single sutures or by wrapping around the implant to gain control of 
the lower pole [3, 24]. Otherwise, sutures may be given in the opposite order. Mesh 
Figure 2. 
Recommended implantation procedure in prepectoral reconstruction.
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allows to create a more spacious pocket with a natural inframammary fold, bridging 
the gap between the muscle and chest wall fascia [3, 7] and protecting the pectoralis 
major from cranial movement.
In the prepectoral IBBR, the mesh or matrix is folded onto itself to create a 
pocket for the implant or the expander (filled with its final expansion volume and 
then deflated), and this pocket is sutured to the pectoral major fascia with at least 
three stitches, apical, medial, and lateral [25]. Advantages of this approach include 
less tissue dissection, less postoperative pain, better filling of the medial breast, 
avoidance of lateral fallout, and absence of hyperanimation deformity. This tech-
nique is frequently used in combination with new technologies such as autologous 
fat grafting and perfusion analysis of the skin flaps.
5. Complications
Mesh use in breast reconstruction is associated with many complications. 
Infection, seroma, hematoma, capsular contracture, skin flap necrosis, explantation 
or implant loss are the most commonly reported. Of course, some characteristics of 
patients are associated with increased complication rates, with or without use of a 
mesh. These include age (older than 65 years), large breasts (more than 600 g), obe-
sity (BMI greater than 30), smoking, diabetes, hypertension, long drain removal 
time, previous radiotherapy to the ipsilateral breast, and receipt of neoadjuvant 
chemotherapy [1, 2].
Infection is one of the most common complications seen in both biological and 
synthetic mesh use, which often leads to tissue necrosis and may result in explanta-
tion, revision, or even complete loss of implant [1, 26]. Ellis et al. reported rates of 
infection shifting between 0.2 and 35.8%, the higher numbers seen after ADM use 
[1, 2]. A high-throughput assay comparing synthetic meshes (Prolene and Vicryl) 
and biological matrices (Alloderm and Flex HD) as substrates for bacterial adhesion 
concluded that Staphylococcus aureus adhered more readily to ADMs than to meshes, 
therefore showing a greater potential propensity for biofilm development [27].
Seroma and haematoma are commonly occurring complications and can both 
lead to an increased risk of infection and tissue necrosis, particularly when large 
enough to require drain insertion. Haematoma formation is thought to occur in the 
immediate postoperative period as a result of trauma during surgery—although the 
use of electrocautery has significantly reduced its incidence—or as a late compli-
cation due to small tears in the capsule formed around the implant, often after 
physical trauma [1]. There seems to be different seroma formation rates between the 
two types of meshes. Matrices have smooth surfaces, allowing increased fluctuation 
between the matrix and the subcutaneous tissue and resulting in the development 
of seromas. Meshes have rougher surfaces and thus a potentially faster interaction 
with the subcutaneous tissue, lesser fluctuation, and a consequent decrease in 
seroma formation [10]. Rates are between 0 and 5.7% for meshes and between 1.5 
and 24.3 for ADM [1].
Capsular contracture is described as the formation of a fibrous capsule around 
the implant that thickens progressively and may contract, compressing the implant 
and resulting in a hard breast with deformed contouring of the surrounding skin. 
This may also cause severe pain due to nerve entrapment or muscle mobility inter-
ference. Although the aetiology is unclear, some believe that it is initiated by blood 
products like haematomas, while others consider infection and chronic inflam-
mation to be most likely the cause, either by bacteria colonisation from within the 
ductal breast tissue or from the skin [1, 28]. Studies have reported significantly 
lower rates of capsular contracture with the use of ADM than without it, but the 
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length of the follow-up is short [20]. Although no high-quality study has directly 
compared the incidence of capsular contracture between synthetic and biological 
matrices IBBR, rates are similar for both types (1.3–8.6% for meshes and 0.4–8.1% 
for matrices) [1, 3, 28, 29]. Dieterich et al. [30] reported a histological analysis with 
mild inflammation using TiLOOP, suggesting a low risk of capsular contracture.
Loss of vascular supply to the overlying mastectomy skin flap is the reason 
of skin necrosis after ischaemic changes. This is a multifactorial event: patient 
comorbidities, thin mastectomy skin flaps, or over expansion may contribute [1]. 
Regarding the surgical technique, rates of skin necrosis up to 30% have been associ-
ated with the use of inverted T-incision, especially at the T-junction [24].
Rates of 1.8–4.3% for meshes and 1.4–24.3% for matrices have been published [1].
All of the above complications, if severe enough, may lead to implant explan-
tation, often resulting in complete implant loss. Most of the studies showed 
comparable rates of implantation loss using matrices or synthetic meshes 
(between 0 and 8.7%), although some reports explantation rates as high as 
33.3% for ADM [1, 29].
6. Discussion
Reconstructive breast techniques with expander or implant without biologic or 
synthetic meshes can have disadvantages. In the short run, they may present with a 
thin or insufficient coverage of the implant, a risky stress of the inferior pole along 
with a decreased skin perfusion with a too early or too extensive expansion, and a 
herniation and sequential skin erosion towards the lateral border of the pectoralis 
major muscle or the inferior pole. In the medium and long term, a high-riding 
implant due to muscle stiffness, a restricted expansion of the inferior pole, or a 
loss of definition of the inframammary fold may appear. By using these meshes to 
support and cover these weak points, these disadvantages can be diminished or even 
resolved [30].
Benefits of their use include improved coverage over the device, lengthening and 
support of the pectoralis muscle, support for the lower pole, more rapid expansion, 
improved definition of the breast boundaries and folds, and possible modifica-
tion of capsule formation. Disadvantages include added risk of infection, seroma 
formation, risk of flap necrosis and implant exposure, added surgical time, and 
increased cost [31, 32]. These complications may be higher than traditional implant 
reconstruction, and there is no yet evidence on long-term outcomes of these mesh 
procedures, including the need for further surgery over time [33].
Although the choice of using a mesh or a matrix is controversial and depends 
basically on individual surgeon preference, there are indications where matrices 
may be advisable, such as in revisional breast surgery or after irradiation, since 
reported data suggest a better blood flow to the irradiated skin and, for some 
author, a decreased rate of capsular contracture compared with meshes [24]. 
Published guidelines, though largely based on poor-quality evidence and expert 
opinion, offer sensible advice regarding current best practice. The American Society 
of Plastic Surgeons recommends using mesh on a per patient basis. The United 
Kingdom professional associations (Association of Breast Surgery and the British 
Association of Plastic, Reconstructive, and Aesthetic Surgeons) advocate careful 
patient selection and employing mesh-assisted IBBR with caution in high-risk 
groups (current smokers, previous breast radiotherapy, high BMI) [21, 34]. A joint 
consensus guide on prepectoral IBBR from European and US surgeons has been 
recently published [35]. After a systematic review, Cabalag et al. offer a summary of 
recommendations for ADM use [36].
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Regarding outcomes when using these materials, a recent systematic review 
noted a higher rate of infection with mesh-assisted IBBR than traditional IBBR, but 
the quality of evidence is low [37]. Improved cosmetic results have been advocated 
for the use of matrices, although the outcomes of the reported studies are of limited 
value [20, 29]. Sigalove et al. found less than 5% of aesthetic complications (capsu-
lar contracture, implant malposition, and rippling) after prepectoral reconstruction 
with ADM. Their complication rate was 9.1%: 4.5% infections, 2.0% seromas, and 
2.5% necrosis [38]. Obtaining data from 14,249 patients, Pannucci et al. reported 
a significant increased risk of 0.7% (1.85 vs. 2.58%) expander/implant loss when 
ADM was used [39].
Salibian et al. showed 85.2% of patients as having very good or good results 
with prepectoral expander/implant without any additional material (together with 
infection in 2.4%, necrosis in 6.8%, capsular contracture Baker grade III or IV in 
7.6%, and rippling in 3.6% of the patients) [40].
In a small pilot randomised controlled trial comparing biological and synthetic 
meshes, Gschwantler-Kaulich et al. [24] found no statistically significant differ-
ences in cosmetic outcome and overall complications between the groups, but 
patients in the ADM group experienced substantially higher rates of implant loss 
than those undergoing IBBR with synthetic mesh (although the first group was 
more exposed to radiotherapy). Nevertheless, this study is insufficiently designed 
to look at the target difference between the treatment groups and is of very low-
quality evidence.
A recent cohort study reported no differences in satisfaction and quality of life 
between the use of matrix (Surgisis) or mesh (TIGR) in IBBR [41]. Reitsemer et al. 
reported low complication rates after 200 prepectoral reconstructions with the use 
of ADM or TIGR mesh, but with no comparison between both [42]. A systematic 
review comparing subcutaneous IBBR using ADM or meshes (without any infor-
mation about the types of meshes) concluded that short-term complication rates 
are low and similar but refers that statistical analysis was not possible given dif-
fering study designs, confounding variables, and lack of comparative data in each 
study [43].
In a retrospective cohort study comparing the benefits of mesh (TiLOOP) 
versus non-mesh reconstructions, there was no statistical significance either in 
complications or in patient-reported outcomes [3]. In a large retrospective mul-
ticenter study of 231 procedures using synthetic mesh (TiLOOP Bra), Dieterich 
revealed major complications (those needing additional surgery) occurring in 
13.4%, minor complications (requiring just conservative measures) in 15.6%, and 
implant loss in 8.7% of patients. The overall infection rate was 6.1% of which only 
1.7% needed revision, and the seroma rate was 4.8%. In this chapter, risk factors 
for postoperative complications included a bilateral procedure or a previous skin 
expansion. The authors concluded that these were acceptable complication rates, 
that the mesh should only be used in primary cases, and that, when adhering to the 
proposed indications, it was a safe and convenient option in implant-based breast 
reconstruction [26].
Low complication rates (6.6%, including implant loss of 1.3%) and good aes-
thetic results have also been reported by Tessler et al. with the use of Vicryl meshes, 
which add to their economic advantage over matrices, but again with insufficient 
power to obtain clear-cut conclusions [44].
Hallberg et al. noticed complications in 23% of the patients with IBBR using 
TIGR Matrix, including two implant losses. Reported risk factors were age over 
51 years, BMI over 24.5 kg/m2, large resection weight, and a Wise pattern excision 
of the skin [45]. A similar rate of complications with the same material was stated 
by Pompei et al., with 11.6% of the patients requiring revisional surgery but with 
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removal of the mesh only in 3.3% of them. These authors found that this mesh 
caused low seroma (3.6%) and infection rates (1.6%) when compared with other 
nonreabsorbable or semiresorbable synthetic meshes, but also this study has a low 
quality of evidence [46]. A recent abstract reports on 34 patients reconstructed 
with TIGR Matrix encountered 9% cases with infections, 9% with necrosis, 5.9% 
with seromas, and 3% with reoperations [47]. Schrenk et al. found just one case of 
seroma and another of skin necrosis, needing reoperation, after 37 IBBR with the 
same mesh [48]. Irwin et al. had 11 implant losses out of 94 cases with the same 
material [49].
In a prospective study with 187 patients treated with prepectoral expander and 
TiLOOP Bra mesh and with a mean follow-up of 36.5 months, Casella et al. found 
complications requiring a second operation in 6.7% of the cases, with implant loss 
in half of them. Capsular contracture, implant malposition, and, above all, rippling 
appeared in 16.4%. Patients scored a high level of satisfaction [50].
In a study comparing reconstruction with a prepectoral titanium mesh wrap to 
subpectoral titanium sling, there was only one implant failure in the prepectoral 
cohort. There were no significant differences between the two groups with any 
complication, including infection, implant loss, skin necrosis, hematoma, or 
reoperation at 1-year follow-up [51]. Two-year follow-up demonstrated no capsular 
contracture in the prepectoral cohort and 12% in the partial subpectoral cohort 
[52]. Other paper by Casella et al. on 250 cases of prepectoral implant immedi-
ate reconstruction and TiLOOP recounts complications in 2.4% of the cases, but 
aesthetic complications are brought to reoperations in 19.5% of the breasts [53].
A reported side effect of titanium-coated permanent mesh in IBBR is the for-
mation of granulomas in the inframammary fold, probably in the area where the 
mesh had been folded or fixed, mimicking a local recurrence [54]. Other papers 
state good cosmetic results and/or a low rate of complications with the use of this 
mesh [3, 55, 56].
A retrospective analysis of 320 cases comparing TiLOOP Bra mesh with 
SERAGYN mesh reported no differences in complication rates (and no differences 
in performance when compared to ADM) [58, 59]. A similar report about 131 
patients with SERAGYN showed a rate of complication comparable to the use of 
other meshes or matrices (seroma in 25.7%, reconstructive failure in 11.5%, wound 
healing issues in 13.5%, wound infections in 10.8%), without severe complications 
in 83.8% of operations [60]. Other retrospective study with 102 patients and 174 
IBBR using ULTRAPRO, which included 45.1% patients with previous radiotherapy 
and pre-existing scars, recorded complications in 18.3%, (6.9% minor and 11.4% 
major, requiring revision) [19]. A similar report with 70 cases of reconstructed 
breast using SURGIMESH found no statistical significances in outcomes compared 
with standard IBBR without meshes [61]. Another paper about the use of polyester 
mesh (Mersilene) in 73 patients reported an explantation rate of 4.1%, although 
the surgical technique included an abdominal advancement flap [62]. One abstract 
reported similar results with polyester mesh, titanium mesh, and ADM in 104 
cases, with excellent results in 67.3% of them [63].
The best report till the date is a prospective, multicentre cohort study in the 
United Kingdom, where 2108 patients were recruited to establish the short-term 
safety of immediate IBBR performed with and without mesh, either biological or 
synthetic, in prepectoral or submuscular pockets. After 3 months of surgery, 9% of 
the patients suffered implant loss, 18% required readmission, 18% needed a second 
surgery because of the complications, and 25% had treatment for an infection, 
with no differences regarding mesh use or type [2]. This analysis also identified 
an association between infection and previous radiotherapy. Ages, neoadjuvant 
chemotherapy, bilateral surgery, indication for surgery, nipple-sparing procedure, 
B
reast C
an
cer an
d
 B
reast R
econ
stru
ction
10
Ref. 
No
Surgical 
technique
Mesh type Breasts 
no.
Infection Explantation Necrosis Seroma/
hematoma
Contracture 
grade III–IV
Reoperation Total Aesthetic 
Ex+G
RT
[2] All ADM
TiLOOP
1133
243
22.0
26.0
8.0
10.0
17.0
20.0
7.0
[3] All TiLOOP
None
48
42
6.0
14.2
4.1
14.2
2/0
6/4.1
4.1
16.6
6.0
4.1
21.1
28.6
NS
[8] Submuscular TIGR 54 1.7 5.0 3.3/6.7 1.7 11.6 23.3 10.2
[9] TiLOOP
Strattice
79
35
6.0
6.0
18.0
22.0
[19] Submuscular ULTRAPRO 174 4.5 4.0 5.1/1.2 1.2 6.3 18.3 41.5
[21] Revisional TIGR 112 3.6 1.8 1.8 15.2 20.5 14.5
[22] P4HB
ADM
110
198
8.0
15.0
6.0
8.0
28.0
37.0
[24] Protexa
TiLOOP
25*
23*
12.0
4.3
30.4
7.7
12.0
4.3/8.6
39.1
24.0
79.0
87.5
16.0
0.0
[26] Submuscular TiLOOP 231 6.1 8.7 4.3 4.8/9.5 2.2 29.0 2.1
[41] Surgisis
TIGR
116
65
15.1
4.9
5.5
4.9
35.8
29.3
NS
[42] Prepectoral ADM and 
TIGR
200 3.5 0.0/4.0 0.0 90.0 13.0
[44] Submuscular Vicryl 76 1.3 1.3 2.6 0.0/0.0 1.3 3.9 6.6 18.4
[45] Submuscular TIGR 65 1.5 3.1 1.5 3.1/1.5 1.5 23.2
[46] Submuscular TIGR 54 1.7 5.0 3.3/6.7 1.7 11.6 10.2
[47] All TIGR 40 7.5 7.5 5.0/0.0 22.5
[48] Submuscular 
expander
TiLOOP 237 2.5 1.3 1.2/0.0 3.8 6.7 BREAST-Q 1 26.5
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Ref. 
No
Surgical 
technique
Mesh type Breasts 
no.
Infection Explantation Necrosis Seroma/
hematoma
Contracture 
grade III–IV
Reoperation Total Aesthetic 
Ex+G
RT
[49] Submuscular
Prepectoral
TiLOOP 34
39
5.8
0.0
0.0
2.5
0.0
2.5
0.0/0.0
0.0/2.5
[51] Prepectoral TiLOOP 250 0.8 1.2 0.8 0.0/0.4 4.0 2.4 BREAST-Q 2 7.2
[53] TiLOOP 87* 10.3 9.2/17.2
[57] Submuscular TiLOOP 269* 0.7 0.3 BREAST-Q 3 9.7
[60] All SERAGYN 148 14.2 8.1 25.7/14.2 1.4 22.9 17.6
[19] Submuscular ULTRAPRO 174 4.5 4.0 5.1/1.2 1.2 11.4 45.1
[61] Submuscular SURGIMESH
None
70
136
10.0
5.88
7.1
10.0
10.0
10.0
8.5/1.4
7.3/0.0
7.1 12.7
[62] Submuscular Mersilene 73* 1.4 4.1 13.6 19.2 77.5
Aesthetic Ex+G: aesthetic results excellent and goods.
RT: % of cases with pre- and postoperative radiotherapy.
NS: not significant.
*Number of patients (number of cases not reported).
BREAST-Q 1: overall satisfaction with outcome 74.0, satisfaction with breasts 72.2, psychosocial wellness 77.5, and sexual well-being 61.6.
BREAST-Q 2: overall satisfaction with outcome 73.8, satisfaction with breasts 72.5, psychosocial wellness 77.7, and sexual well-being 57.9.
BREAST-Q 3: overall satisfaction with outcome 74.8, satisfaction with breasts 60.2, psychosocial wellness 71.3, and sexual well-being 56.4.
Table 1. 
Number of complications is given in percentage.
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fixed-volume implant, and type of reconstruction were not significant risk factors. 
A summary of all these data is shown in Table 1. A number of studies are currently 
underway in Europe [64].
It is well known that radiotherapy has a significantly detrimental effect on 
most breast reconstruction outcomes, whether given pre- or postoperatively (but 
without differences in complication rates between both) [65], since it impedes 
neovascularisation and mesh incorporation into the host [1]. Most published studies 
identify radiotherapy as adversely affecting the cosmetic outcome by precipitat-
ing the inflammatory reaction of the implant to the surrounding tissues. Becker 
described frequent complications in patients that received radiotherapy and were 
reconstructed with TIGR mesh [21]. Similar results were reported by Dieterich 
et al. using TiLOOP mesh [26] and by others using ADM [1, 4, 66–68]. On the other 
hand, some protective effects of matrices against radiotherapy, compared with 
those patients without them, have been reported, since biological meshes appear to 
limit the elastosis and chronic inflammation seen in irradiated IBBR [69, 70].
To sum up, the literature on this subject is difficult to interpret because there 
is neither high-quality evidence comparing outcomes of mesh-assisted IBBR with 
traditional IBBR or comparing matrices with meshes. Most studies in this area are 
small, single-centre, retrospective cohort studies and case series with methodologi-
cal limitations: different surgical techniques, with different meshes and matrices, 
differing in sizes and positions, with very disparate ways of reporting complications 
(in fact, it is often unclear what complications have been included and how they 
have been diagnosed and how and when capsular contracture and aesthetic out-
come have been evaluated), thus carrying a low level of evidence [37]. Randomised 
clinical trials with sufficient periods of follow-up should be carried out to determine 
whether the cost of these products is justified in terms of the benefits provided [71].
7. Conclusions
Although it is still unclear whether mesh procedures are a safe alternative to 
traditional IBBR regarding patient-reported outcomes, matrices and meshes have 
proven to wear valuable advantages. Moreover, there is not even a consensus on 
which of the two types produces the best outcomes, although there is a trend to 
consider that meshes bring comparable aesthetic outcomes to matrices, with lower 
costs and complication rates. Regarding the uncertainty about the best position for 
the implant, either submuscular or subcutaneous, the prepectoral position is gain-
ing ground quickly among surgeons and patients.
Most of the literature have focused on the complication and safety profiles of 
these meshes, but, given that the purpose of breast reconstruction is to improve 
body image and psychosocial function, it is equally important that cosmesis 
and patient satisfaction are also included when evaluating the results of these 
techniques.
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